A lean initiatives program, undertaken over a period of years to improve quality and on-time delivery, has been a boon to the company’s ability to meet medical device makers’ needs. About three years ago, the company refocused its ongoing lean manufacturing initiatives to take aim at improving the company’s bottom line by eliminating waste while improving quality and delivery.
The European market for orthopedic biomaterials saw a decline between 2010 and 2012 due to a period of economic uncertainty and severe budgetary restrictions. However, this rate of decline has been diminishing, a promising sign for future growth.
The TomoTherapy System boasts one of the most reliable uptime rates in the industry at approximately 99 percent, but when shortcomings with a supplier’s couplings for the system’s electro/pneumatic/mechanical assembly threatened its accuracy and uptime, Accuray sought an immediate solution.
While machining may not be specified as much as it once was in the medical device industry (outside of the orthopedic realm, that is), it is still very much a necessary component fabrication process for this industry. In fact, machining is being utilized across an array of device sectors, from surgical tools, fixation devices, and dental implants to components for medical pumps, instrumentation, and implantables.
While the use of disposables in healthcare is certainly nothing new, their implementation as instrumentation in orthopedic procedures is. Offering an array of benefits for OEMs and hospitals alike, such as cost savings, improved efficiencies, and enhanced safety, without sacrificing the durability and strength of more traditional instruments, it’s no wonder this trend is occurring.
Within the medical device technology industry, the cardiovascular sector is one of the largest and most stable, due to immediate demand and necessity. As with all areas in the field, engineers continuously strive to design more minimally invasive devices, but with cardiovascular diseases at the top of the list in a growing elderly population, there is an urgent need for continuous advancement.
Leading companies and institutes in protein diagnostics and micro-nano-bio research, including Philips, imec, Hytest, PolyAn, Bremen University, and Eindhoven University of Technology, have joined forces to investigate next-generation technologies with the goal of enabling new, highly sensitive, point-of-care blood tests.
Brain imaging equipment has been around since the 1930s, but we have made very little progress in understanding the human brain, explains Tan Le, Founder and CEO of Emotiv Insight. With almost a decade of experience in the field, she hopes to change this.
Sensors are used to measure gas flows for various purposes in modern medical ventilation technology. A variety of measuring principles are used, depending on the manufacturer and the intended use, and as such, many different sensor products are now available on the market.
A new test has been developed for medical device manufacturers and biomaterials researchers to screen plastics, composites, and polymers for toxicity. This ZET test utilizes zebrafish (Danio rerio). Zebrafish are extensively used in drug development studies due to their transparent embryos and fast development times.
With the launch of the new Olympus WM-P2 series of workstations, Olympus KeyMed has created an ergonomic and efficient platform design, including a flexible arm to support the viewing monitor, in partnership with Southco. It was the company’s new patented positioning technology AV arm series that was to provide the key to the creation of a cutting edge monitor mounting solution.
Regulations for the Restriction of Hazardous Substances (RoHS) 2 impact the ways in which companies do business, especially in the medical device industry. On July 22, 2014, when a company places a CE mark on medical devices, they are confirming all appropriate measures were taken to ensure each product meets the RoHS 2 directive...
The Federal Communications Commission (FCC) regulatory requirements are generally present in Subpart E of Part 95, which sets forth technical requirements that apply across all Personal Radio Services. The existing MedRadio provisions in Subpart E were amended in September 2012 to include the 2360-2400 MHz band requirements...
Few materials testing systems are able to measure low capacity and small displacement movements on samples that can often be difficult to hold. Furthermore, many researchers have a need to record microscopic material behavior while the sample is subjected to forces. In this article, three examples that demonstrate how the Microtester was deployed in the market are featured.
Ensuring compliance with IEC 60601-1 is simply a must for every medical device manufacturer. However, with revisions and updates, it’s difficult for a company to ensure they are constantly in compliance unless they have a dedicated expert on staff. Therefore, an excellent solution for this challenge is to partner with a company that is exactly that—an expert on the standard.